Antenatal testing for STIs and BBVs has been recommended by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) since 1992. In 2007, the Department of Health, Western Australia (DoH) issued an Operational Directive (OD) recommending additional testing for chlamydia, repeat testing at 28-36 weeks gestation if at high risk and further testing, including gonorrhoea, for those in the STI-endemic region of WA.
To assess adherence to both these guidelines, baseline and follow-up audits were conducted at seven WA public hospitals to determine the proportion of women who had antenatal STI and BBV testing.
Each hospital provided antenatal records of the last 200 women who delivered immediately prior to 1st July 2007 (baseline) and 30th June 2010 (follow-up). Basic demographic details and STI and BBV testing information were collected.
The records of 2,799 women were examined (baseline: n=1,400; follow-up: n=1,399). At both baseline and follow-up audits, the majority of women were tested for syphilis (baseline: 90%; follow-up: 94%), HIV (79%; 89%), hepatitis B (92%; 97%) and hepatitis C (90%; 94%). There was significant improvement in testing for chlamydia (20%; 66%) and gonorrhoea (24%; 55%). From baseline to follow-up, there was an increase in the proportion of women who had all STI and BBV tests at their first antenatal visit at a GP or hospital as recommended by RANZCOG (67%; 74%) and the DoH OD (11%; 39%). The highest test positivity rates were for chlamydia (4% of those tested at both baseline and follow-up). A high proportion of women in WA hospitals have antenatal tests for most STIs and BBVs. The proportion who had antenatal STI and BBV tests as recommended by RANZCOG and the DoH OD improved between 2007 and 2010 and there was substantial improvement in chlamydia and gonorrhoea testing in particular.
Over the past 20-30 years, the Premature Ejaculation (PE) treatment paradigm, previously limited to behavioural psychotherapy, has expanded to include drug treatment. Animal and human sexual psychopharmacological studies have demonstrated that serotonin and 5-HT receptors are involved in ejaculation and confirm a role for SSRIs in the treatment of PE. Multiple well-controlled evidence-based studies have demonstrated the efficacy and safety of SSRIs in delaying ejaculation, confirming their role as first-line agents for the medical treatment of lifelong and acquired PE. Daily dosing of SSRIs is associated with superior fold increases in IELT compared to on-demand SSRIs.
Despite high rates of screening and treatment in many remote Indigenous communities in Australia, diagnosis rates for sexually transmitted infections (STI), chlamydia and gonorrhoea in particular, remain alarmingly high. One contributing factor may be the high rate of temporary mobility for residents of remote communities. We use mathematical modelling to explore the impact of mobility on STI transmission within remote communities.
In 2006 two new innovative features were added to the WhyTest website; the ‘Tell them’ service allowing visitors to forward anonymous e-postcard or short message services (SMS) to sexual partners who may have been exposed to an STI, and the ‘remind me’ service allowing visitors to register for a 3, 6 or 12 monthly SMS reminder for a sexual health check. We describe the usage of the new website functionality, and recognition of a health promotion campaign conducted in January-June 2007 to promote these new features.
This symposium presentation will discuss conceptual approaches to how processes underway to develop the Australian Curriculum might link to improved sexual health outcomes. It will also explore the assumptions underpinning the ‘partnership’ between health and education sectors to uncover both the opportunities and the pitfalls for those who want to promote young people’s learning.
Human papillomavirus (HPV) induced oropharyngeal squamous cell carcinoma is a unique subtype of oropharyngeal cancer. It has a significantly better prognosis than that caused by tobacco and/ or alcohol. The incidence of HPV related oropharyngeal cancer is raising in the western countries.
ACCEPt is a multi-state cluster randomised trial that aims to increase annual chlamydia testing in 16-29 year olds attending general practice. 54 postcodes (80% in rural areas) are being randomised to a multi-faceted intervention and GP clinics within each postcode enrolled. The primary outcome is change in chlamydia prevalence, and a prevalence study is being conducted at the beginning and end of the trial. We report on the findings of the baseline prevalence study.
Surgery for gender dysphoria was not routinely available prior to the 80’s, surgery and psychiatry having had an unhappy liaison. While gender dysphoria is DSM classified it’s not because it is deemed to be an illness, rather than to give guidelines as to establishing a diagnosis, and surgery is now deemed to be an appropriate activity.
This presentation, "Responding to the needs of consumers with complex trauma histories a consumer perspective" focuses on the needs of adult survivors of child abuse, highlighting the frequent